
Ryan N. Henderson
Examiner (ID: 2057, Phone: (571)270-1430 , Office: P/3779 )
| Most Active Art Unit | 3795 |
| Art Unit(s) | 3739, 3795, 3779 |
| Total Applications | 931 |
| Issued Applications | 516 |
| Pending Applications | 102 |
| Abandoned Applications | 329 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5526777
[patent_doc_number] => 20090196854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR USE OF CRL 5803 CELLS FOR EXPRESSION OF BIOTHERAPEUTICS AND ENCAPSULATED CELL-BASED DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 12/025392
[patent_app_country] => US
[patent_app_date] => 2008-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 41211
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20090196854.pdf
[firstpage_image] =>[orig_patent_app_number] => 12025392
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/025392 | METHODS AND COMPOSITIONS FOR USE OF CRL 5803 CELLS FOR EXPRESSION OF BIOTHERAPEUTICS AND ENCAPSULATED CELL-BASED DELIVERY | Feb 3, 2008 | Abandoned |
Array
(
[id] => 1076863
[patent_doc_number] => 07615374
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-10
[patent_title] => 'Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions'
[patent_app_type] => utility
[patent_app_number] => 12/024770
[patent_app_country] => US
[patent_app_date] => 2008-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4266
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/615/07615374.pdf
[firstpage_image] =>[orig_patent_app_number] => 12024770
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/024770 | Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions | Jan 31, 2008 | Issued |
Array
(
[id] => 4866802
[patent_doc_number] => 20080145861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Methods of protein production in cell lines'
[patent_app_type] => utility
[patent_app_number] => 12/012387
[patent_app_country] => US
[patent_app_date] => 2008-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13215
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145861.pdf
[firstpage_image] =>[orig_patent_app_number] => 12012387
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/012387 | Methods of protein production in cell lines | Jan 31, 2008 | Issued |
Array
(
[id] => 6143480
[patent_doc_number] => 20110129928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Method of Manufacturing Induced Pluripotent Stem Cell Originated from Somatic Cell'
[patent_app_type] => utility
[patent_app_number] => 12/865690
[patent_app_country] => US
[patent_app_date] => 2008-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4881
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129928.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865690
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865690 | Method of Manufacturing Induced Pluripotent Stem Cell Originated from Somatic Cell | Jan 30, 2008 | Abandoned |
Array
(
[id] => 4739970
[patent_doc_number] => 20080233623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'GENETICALLY MODIFIED HOST CELLS FOR INCREASED P450 ACTIVITY LEVELS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/021974
[patent_app_country] => US
[patent_app_date] => 2008-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23954
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233623.pdf
[firstpage_image] =>[orig_patent_app_number] => 12021974
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/021974 | GENETICALLY MODIFIED HOST CELLS FOR INCREASED P450 ACTIVITY LEVELS AND METHODS OF USE THEREOF | Jan 28, 2008 | Abandoned |
Array
(
[id] => 5379316
[patent_doc_number] => 20090191155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'COMPOSITIONS AND METHODS FOR AMELIORATING MYOSIN VIIA DEFECTS'
[patent_app_type] => utility
[patent_app_number] => 12/021078
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16637
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191155.pdf
[firstpage_image] =>[orig_patent_app_number] => 12021078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/021078 | Compositions and methods for ameliorating myosin VIIa defects | Jan 27, 2008 | Issued |
Array
(
[id] => 4837641
[patent_doc_number] => 20080134352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Method for producing transgenic rats'
[patent_app_type] => utility
[patent_app_number] => 12/011762
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 14481
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20080134352.pdf
[firstpage_image] =>[orig_patent_app_number] => 12011762
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/011762 | Method for producing transgenic rats | Jan 27, 2008 | Issued |
Array
(
[id] => 5379330
[patent_doc_number] => 20090191169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Methods for gene transfer to mammals'
[patent_app_type] => utility
[patent_app_number] => 12/010426
[patent_app_country] => US
[patent_app_date] => 2008-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6753
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191169.pdf
[firstpage_image] =>[orig_patent_app_number] => 12010426
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/010426 | Method for transforming a hair follicle | Jan 23, 2008 | Issued |
Array
(
[id] => 8528030
[patent_doc_number] => 08304601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-06
[patent_title] => 'Mouse model for eye disease'
[patent_app_type] => utility
[patent_app_number] => 12/524268
[patent_app_country] => US
[patent_app_date] => 2008-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 6506
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524268
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524268 | Mouse model for eye disease | Jan 22, 2008 | Issued |
Array
(
[id] => 6062122
[patent_doc_number] => 20110200579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO'
[patent_app_type] => utility
[patent_app_number] => 12/375668
[patent_app_country] => US
[patent_app_date] => 2008-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 61460
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20110200579.pdf
[firstpage_image] =>[orig_patent_app_number] => 12375668
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/375668 | NOVEL GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO | Jan 21, 2008 | Abandoned |
Array
(
[id] => 6513831
[patent_doc_number] => 20100011455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'STEM CELL GENE TARGETING'
[patent_app_type] => utility
[patent_app_number] => 12/523632
[patent_app_country] => US
[patent_app_date] => 2008-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10898
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20100011455.pdf
[firstpage_image] =>[orig_patent_app_number] => 12523632
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523632 | Targeting the Rosa26 gene in human embryonic stem cells | Jan 17, 2008 | Issued |
Array
(
[id] => 4873833
[patent_doc_number] => 20080200567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'IN VIVO SCREENING MODELS FOR TREATMENT OF ALZHEIMER\'S DISEASE AND OTHER QPCT-RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/016266
[patent_app_country] => US
[patent_app_date] => 2008-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 21736
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200567.pdf
[firstpage_image] =>[orig_patent_app_number] => 12016266
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/016266 | IN VIVO SCREENING MODELS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER QPCT-RELATED DISORDERS | Jan 17, 2008 | Abandoned |
Array
(
[id] => 8870356
[patent_doc_number] => 08465732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-18
[patent_title] => 'Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/523372
[patent_app_country] => US
[patent_app_date] => 2008-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 10
[patent_no_of_words] => 13812
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12523372
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523372 | Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof | Jan 17, 2008 | Issued |
Array
(
[id] => 4794212
[patent_doc_number] => 20080295186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Neurotrypsin overexpressing animal'
[patent_app_type] => utility
[patent_app_number] => 12/007928
[patent_app_country] => US
[patent_app_date] => 2008-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7283
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0295/20080295186.pdf
[firstpage_image] =>[orig_patent_app_number] => 12007928
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/007928 | Neurotrypsin overexpressing animal | Jan 16, 2008 | Abandoned |
Array
(
[id] => 314523
[patent_doc_number] => 07524491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Non human animals with human-glial chimeric brains'
[patent_app_type] => utility
[patent_app_number] => 12/015372
[patent_app_country] => US
[patent_app_date] => 2008-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13893
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524491.pdf
[firstpage_image] =>[orig_patent_app_number] => 12015372
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/015372 | Non human animals with human-glial chimeric brains | Jan 15, 2008 | Issued |
Array
(
[id] => 4820340
[patent_doc_number] => 20080226611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Gene Therapy Using TGF-beta'
[patent_app_type] => utility
[patent_app_number] => 12/014715
[patent_app_country] => US
[patent_app_date] => 2008-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10318
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226611.pdf
[firstpage_image] =>[orig_patent_app_number] => 12014715
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/014715 | Gene Therapy Using TGF-beta | Jan 14, 2008 | Abandoned |
Array
(
[id] => 5508446
[patent_doc_number] => 20090081653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Insulin-responsive DNA binding proteins-1 and methods to regulate insulin-responsive genes'
[patent_app_type] => utility
[patent_app_number] => 12/008962
[patent_app_country] => US
[patent_app_date] => 2008-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 89
[patent_figures_cnt] => 89
[patent_no_of_words] => 37821
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081653.pdf
[firstpage_image] =>[orig_patent_app_number] => 12008962
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/008962 | Insulin-responsive DNA binding proteins-1 and methods to regulate insulin-responsive genes | Jan 14, 2008 | Issued |
Array
(
[id] => 5416412
[patent_doc_number] => 20090042299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Vectors and methods for tissue specific synthesis of proteins in eggs of transgenic hens'
[patent_app_type] => utility
[patent_app_number] => 12/008399
[patent_app_country] => US
[patent_app_date] => 2008-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8971
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042299.pdf
[firstpage_image] =>[orig_patent_app_number] => 12008399
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/008399 | Vectors and methods for tissue specific synthesis of proteins in eggs of transgenic hens | Jan 8, 2008 | Abandoned |
Array
(
[id] => 5435616
[patent_doc_number] => 20090170203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'METHODS FOR FEMALE MAMMALIAN SPERMATOGENESIS AND MALE MAMMALIAN OOGENESIS USING SYNTHETIC NANOBIOLOGY'
[patent_app_type] => utility
[patent_app_number] => 11/968180
[patent_app_country] => US
[patent_app_date] => 2008-01-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16548
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170203.pdf
[firstpage_image] =>[orig_patent_app_number] => 11968180
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/968180 | METHODS FOR FEMALE MAMMALIAN SPERMATOGENESIS AND MALE MAMMALIAN OOGENESIS USING SYNTHETIC NANOBIOLOGY | Dec 31, 2007 | Abandoned |
Array
(
[id] => 5522208
[patent_doc_number] => 20090030189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'mTOR GLS and ELS, their small molecule mimetics and competitive inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/001161
[patent_app_country] => US
[patent_app_date] => 2007-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9314
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20090030189.pdf
[firstpage_image] =>[orig_patent_app_number] => 12001161
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/001161 | mTOR GLS and ELS, their small molecule mimetics and competitive inhibitors | Dec 9, 2007 | Abandoned |